Arvind Bhimaraj
@hfdocbhimaraj
Followers
2K
Following
469
Media
330
Statuses
746
Long-term outcomes of light chain amyloidosis patients receiving heart transplant. OHT is an option that programs need to offer for advanced AL cardiac Amyloidosis patients-At the intersection of many specialties. #AmyloidosisAL.
0
1
12
Read our case report. CT overlay guidance for myocardial biopsy. Any fans of Heterotopic heart transplants? .Can we apply this guidance to native heart biopsies?.@AlanLumsdenMD @IssacTea @HMethodistCV .
jhltopen.org
Heterotopic heart transplantation is a surgical technique that has not been embraced broadly. In this historic technique, the donor heart is sutured in parallel to the recipient heart with both...
1
0
4
Does the answer to promoting a sustained recovery state vs a remission state lie in these genes? . A finite set of dysregulated genes seem to persist in mice despite phenotypic normalization. @HMethodistCV @StavrosDrakos @NavinKapur4.
jhltopen.org
Heart failure (HF) remission involves the normalization of cardiac function but is accompanied by a risk of relapse. The key to achieving (complete) recovery may lie in identifying genes that remain...
1
4
7
Looking forward to the mission of spreading awareness on Amyloidosis at our 3rd Annual conference. Tomorrow for patients and their caregivers and on Saturday for medical professionals. Still time to register- virtual option available
0
4
8
Read our recent physiology investigation looking at patients getting M-TEER using clinical invasive PV loop assessment.
🚨Our latest research in #JACCAdvances: "Understanding the effects of M-TEER on LV function using pressure-volume loops". Key findings post M-TEER.✅ No significant change in invasive indices of LV contractility.✅Tau is significantly prolonged .✅ LV chamber stiffness remains.
1
4
16
An amazing initiative by @JeanBismuth to have an honest and open discussion of what doctors face in their life. Congratulations @JeanBismuth.
podcasts.apple.com
Podcast Episode · The Missing Needle · S1 Trailer · 9m
0
0
1
High risk ->refer to center with amyloid txp. exp.-Especially AL. Heme community needs to know this. Congrats on your work. Hope to get our Exp. With 31 pt AL amyloids showing similar results. @JLRosenthal @MelissaLyleMD.
Excited to share @MayoClinic experience with #amyloid and🫀transplant.📌 Post tx survival #amyloid = non-amyloid pts .📌 ⬇️ wait times for #amyloid after allocation change.📌 ⬇️ multi- organ tx with TTR targeted therapies .@MayoAmyloid
0
0
5
Thanks to @GTorreAmione for this opportunity for me to work with @TecCardiology research team to enhance collaborative research in HF. Look forward to working with @g_garcia_rivas @omarlg81 and the rest of the team. Great discussions and great potential.
Outstanding lecture by Dr. Bhimaraj. There is still much to learn about myocardial recovery.
0
1
6
Predicting the Future for AL Amyloidosis Patients .Need torisk prognosticate amyloid patients. Risk driven by cardiac and important to set baseline and follow closely. Read our editorial for an important study by @vsanchorawala @mahwash_kassi @DipanJShah.
0
3
10
Honor to represent CSWG at #TCT2024 to present Axillary IABP and Femoral IABP outcomes. Ax-IABP use increasing for HF-CS, more Ax-bridged to HRT and Overall hospital Survival better in Ax-IABP group. @NavinKapur4 @ReshadGaranMD @JHMontfort10 @manreetkanwar @rachkataria
1
10
38
Thanks to@crfheart for recognizing our abstract as Top 10 at #TCT2024. Thanks to CSWG for the opportunity @NavinKapur4 @manreetkanwar and other leadership and collaborators at CSWG. Come attend my presentation on Monday at #TCT2024 @MethodistHosp @WilliamZoghbi
1
3
19
Congratulations to @GTorreAmione and Vicente Jiminez who put up an amazing conference on Cardiogenic shock. insightful conversation and winds of change for the country of Mexico. @JHMontfort10 @BurkhoffMd @rachkataria
0
1
11
Team work is important but the individuals who make the team make the difference. Well said @Babar_Basir . @TecdeMonterrey organized Cardiogenic shock conference - changing paradigms of shock in Mexico.
1
1
12
An amazing learning opportunity. Boot camp style for CV fellows starting in July . @NadeenFaza.
💥💥A few spots left💥💥.Starting your CV fellowship in July? Sign up for the Methodist DeBakey Boot Camp scheduled on Aug 9-11.🌟Hands-on & didactics sessions. Apply by 6/14:..#ACCFIT #Cardiotwitter #EchoFirst #RadialFirst #EPeeps.Watch video in this 🧵!
0
0
2
The “Forgotten Load” on the heart. Thanks to @NavinKapur4 for his leadership. Mechanical Preload Reduction: Harnessing a Cornerstone of HF therapies @WilliamZoghbi @IsaMathiasMD @NadeenFaza
pubmed.ncbi.nlm.nih.gov
Decongestion is a cornerstone therapeutic goal for those presenting with decompensated heart failure. Current approaches to clinical decongestion include reducing cardiac preload, which is typically...
0
3
13
An amazing grand rounds by @yaleHFdoc. An honest discussion on what it means to be a HF doc in today world and how we need to work on aspects to morph our roles with the evolution of the field. @WilliamZoghbi @khurramn1
0
2
19
Congratulation to Aryan Rezvani, final year med student @TAMU for presenting his case at #ISHLT. @MethodistHosp
0
1
12
Engaging discussions about Cardiogenic shock with the CSWG members on the panel. @ISHLT @NavinKapur4 @BurkhoffMd
0
1
5
“Cardiogenic shock is integral for ISHLT” @UlrichJordeMD - Shock working group session @ISHLT reflecting the phenomenal work done in the 5 years since inception. Thanks to @NavinKapur4 for his vision and leadership. @manreetkanwar @JHMontfort10 @BurkhoffMd #cswg
0
8
38